[Medullary carcinoma of the thyroid gland].
The Authors, after introducing the epidemiology and physiopathology of medullary thyroid carcinoma, compare the most recent diagnostic methods and therapeutic strategies. They highlight recent progress in genetics, in diagnosis and therapy and in the role of labelled radiopharmaceuticals in diagnosis, post-operative therapy and follow-up.
Zarrilli
L
L
Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università degli Studi, Federico II, Napoli.
Marzano
L A
LA
Porcelli
A
A
Zarrilli
S
S
D'Ajello
M
M
D019797:3-Iodobenzylguanidine; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis; D018276:Carcinoma, Medullary / Q000175:diagnosis / Q000628:therapy; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007462:Iodobenzenes / Q000627:therapeutic use; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D011379:Prognosis; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000628:therapy; D013965:Thyroidectomy
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D010281:Parathyroid Hormone; D019797:3-Iodobenzylguanidine; D002116:Calcitonin
Il carcinoma midollare della tiroide.